Notably, autoantibodies directed against cytosolic 5′-nucleotidase 1A (cN1A) have been identified in patients with inclusion body myositis (IBM), Sjögren’s syndrome, systemic lupus erythematosus, and multiple sclerosis [7,8,9,10]. Here, NT5C1A is linked to systemic lupus erythematosus.